Systemic IL-1 and adjuvant treatment of an experimental tumor-Reference-Cited by-同舟云学术

Systemic IL-1 and adjuvant treatment of an experimental tumor

Published:1992-10 Issue:3 Volume:5 Page:227-237
ISSN:0921-299X
Container-title:Biotherapy
language:en
Short-container-title:Biotherapy

Author:

Hornung Ronald L.,Kiertscher Sylvia M.,Mathews Herbert L.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/BF02171055.pdf

Reference29 articles.

1. Nakamura S, Nakata K, Kashimoto S, Yoshida H, Yamada M. Antitumor effect of recombinant human interleukin-1 alpha against murine syngeneic tumors. Jap J Cancer Res (Gann) 1986; 77: 767–773.

2. Ebina T, Ishikawa K. Antitumor effect of interleukin-1 beta in the double grafted tumor system. Jap J Cancer Res 1989; 80: 570–576.

3. McCune CS, Marquis DM. Interleukin-1 as an adjuvant for active specific immunotherapy in a murine tumor model. Cancer Res 1990; 50: 1212–1215.

4. Lachman LB, Dinarello CA, Llansa ND, Fidler IJ. Natural and recombinant human interleukin-1 beta is cytotoxic for human melanoma cells. J Immunol 1986; 136: 3098–3102.

5. Onozaki K, Matsushima K, Aggarwal BB, Oppenheim JJ. Human interleukin-1 is a cytocidal factor for several tumor cell lines. J Immunol 1985; 135: 3962–3968.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An insertion/deletion polymorphism in the interleukin-1A 3'untranslated region confers risk for gastric cancer;Cancer Biomarkers;2016-03-30

2. Interleukin-1—a major pleiotropic cytokine in tumor–host interactions;Seminars in Cancer Biology;2002-08

3. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1 beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor;CANCER GENE THER;2000

4. Biologic basis for interleukin-1 in disease;Blood;1996-03-15

5. Macrophage Expression of Interleukin-1 in Lymphoepithelioid Cell (“Lennert's”) Lymphoma;Leukemia & Lymphoma;1996-01